Treace Medical Concepts Inc reports results for the quarter ended March 31 - Earnings Summary

• Treace Medical Concepts Inc TMCI.OQ reported a quarterly adjusted loss of 25 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -30 cents. The mean expectation of seven analysts for the quarter was for a loss of 30 cents per share. Wall Street expected results to range from -33 cents to -27 cents per share.

• Revenue rose 2.9% to $52.57 million from a year ago; analysts expected $52.07 million.

• Treace Medical Concepts Inc's reported EPS for the quarter was a loss of 25 cents​.

• The company reported a quarterly loss of $15.92 million.

• Treace Medical Concepts Inc shares had fallen by 14.2% this quarter and lost 3.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 19.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

• Wall Street's median 12-month price target for Treace Medical Concepts Inc is $10.00

This summary was machine generated from LSEG data May 8 at 11:15 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)